Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Radiotherapy × Clear all

NCT04947254 2026-02-19

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT05320406 2026-02-12

REVELUTION

Phase 2 Active not recruiting

94 enrolled 13 charts

Prostatic Neoplasms

NCT04879940 2026-02-05

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Phase 2 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms

NCT07202247 2026-02-04

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Phase 2 Recruiting

Prostatic Neoplasms

NCT05568550 2026-01-30

Pembro With Radiation With or Without Olaparib

Phase 2 Recruiting

Prostatic Neoplasms

NCT07364071 2026-01-27

SENTRY

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT06391034 2026-01-07

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT03809000 2025-12-30

STEEL

Phase 2 Active not recruiting

188 enrolled 25 charts

Prostatic Neoplasms

NCT06378866 2025-12-26

DIVINE

Phase 2 Recruiting

Prostatic Neoplasms

NCT04025372 2025-12-15

INTREPId (INTermediate Risk Erection PreservatIon Trial)

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT06150417 2025-11-12

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Phase 2 Recruiting

Prostatic Neoplasms

NCT06244004 2025-10-22

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Phase 2 Recruiting

Prostatic Neoplasms

NCT06528210 2025-09-23

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT04319783 2025-08-21

DECREASE

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT06992232 2025-05-28

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

Phase 2 Recruiting

Prostatic Neoplasms

NCT06582446 2025-03-11

HypoElect

Phase 2 Recruiting

Prostatic Neoplasms

NCT03763253 2025-02-07

IP2-ATLANTA

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04176081 2024-01-24

SChLAP/IDC

Phase 2 Not yet recruiting

BreastGenitourinary

Carcinoma, Intraductal, Noninfiltrating, Prostatic Neoplasms

NCT03649841 2023-10-26

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Terminated

10 enrolled 7 charts

Prostatic Neoplasms

NCT01751438 2023-04-27

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

Phase 2 Completed

Neoplasm Metastasis, Prostatic Neoplasms

NCT05212857 2022-03-16

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT02508636 2021-10-12

Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer

Phase 2 Terminated

11 enrolled 17 charts

Prostatic Neoplasms

NCT00214136 2021-08-04

Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes

Phase 2 Completed

30 enrolled 8 charts

Prostatic Neoplasms

NCT03432780 2021-01-22

QRT-SOGUG

Phase 2 Unknown

Prostatic Neoplasms

NCT04585932 2021-01-20

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00006365 2020-10-22

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT03763851 2020-03-12

Cannabis Oil and Radiation Therapy for the Management of Pain

Phase 2 Terminated

BreastGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT04031378 2019-07-24

Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT02057939 2019-06-26

STREAM

Phase 2 Completed

38 enrolled 12 charts

Prostatic Neoplasms

NCT00528866 2019-04-24

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Phase 2 Completed

80 enrolled 11 charts

Prostatic Neoplasms

NCT01496131 2018-03-09

Tecemotide (L-BLP25) in Prostate Cancer

Phase 2 Completed

28 enrolled 9 charts

Prostatic Neoplasms

NCT02958787 2018-03-05

Vessel Sparing Prostate Radiation Therapy

Phase 2 Completed

135 enrolled 3 charts

Prostatic Neoplasms

NCT00348816 2017-12-08

Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer

Phase 2 Terminated

21 enrolled 10 charts

Prostatic Neoplasms

NCT00551525 2017-07-25

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Phase 2 Completed

67 enrolled 10 charts

Prostatic Neoplasms

NCT01087580 2017-03-03

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00006359 2016-07-18

Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00032006 2016-07-13

Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00016913 2016-07-06

Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Phase 2 Completed

34 enrolled 5 charts

Prostatic Neoplasms

NCT02145494 2014-05-23

SPARC

Phase 2 Unknown

Prostatic Neoplasms

NCT00452556 2014-03-19

The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

Phase 2 Unknown

Prostatic Neoplasms

NCT00003124 2014-01-06

Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00348998 2013-11-06

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT00637637 2013-08-12

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Phase 2 Unknown

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Thyroid Cancer, Papillary, Anus Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mouth Neoplasms, Mycosis Fungoides, Nasopharyngeal Neoplasms, Neoplasms, Wilms Tumor, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Parathyroid Neoplasms, Penile Neoplasms, Pheochromocytoma, Prostatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Sezary Syndrome, Stomach Neoplasms, Tongue Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Endometrial Neoplasms, Lymphoma, Large-Cell, Anaplastic, Adenocarcinoma, Follicular, Adrenocortical Carcinoma, Esthesioneuroblastoma, Olfactory, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Histiocytoma, Malignant Fibrous, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT00003104 2013-06-26

Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00243048 2013-04-05

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00020891 2013-01-18

CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT00040365 2012-04-30

Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer

Phase 2 Completed

30 enrolled 13 charts

Prostatic Neoplasms

NCT00188786 2011-02-15

Cone Beam CT for Daily Image Guidance - Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00003307 2010-03-16

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms, Radiation Injuries